Myrna Weissman | |
---|---|
Born | 1935, April 17 Boston, MA |
Alma mater | Brandeis University, University of Pennsylvania, Yale School of Medicine |
Occupation | Professor of Epidemiology and Psychiatry |
Organization | Columbia University Vagelos College of Physicians and Surgeons, Columbia University Mailman School of Public Health, New York State Psychiatric Institute |
Known for | Interpersonal psychotherapy, Translational Epidemiology, Depression in Families |
Myrna Milgram Weissman is Diane Goldman Kemper Family Professor of Epidemiology in Psychiatry at the Vagelos College of Physicians and Surgeons and Mailman School of Public Health, Columbia University, and Chief of the Division of Translational Epidemiology at the New York State Psychiatric Institute. She is an epidemiologist known for her research on the [[Prevalence of psychiatric disorders|] and psychiatric epidemiology, as it pertains to rates and risks of anxiety and mood disorders across generations. [1] [2] Among her many influential works are longitudinal studies of the impact of parental depression on their children. [3] [4]
Weissman worked with Gerald Klerman in developing Interpersonal psychotherapy (IPT) as one of the first evidence-based treatments for depression. IPT is defined in a manual and now has over 140 clinical trials, numerous transitions, and adaptations. They co-authored with Bruce Rounsaville and Eva Chevron the influential volume Interpersonal Psychotherapy of Depression: A Brief, Focused, Specific Strategy. [5] Extending the approach to adolescents, Weissman co-authored the book Interpersonal Psychotherapy for Depressed Adolescents, with Laura Mufson, Kristen Pollack Dorta, and Donna Moreau. [6] Other books co-authored by Weissman, including The Guide to Interpersonal Psychotherapy: Updated and Expanded Edition, [7] offered further developments of their psychotherapeutic approach. Weissman and Klerman were jointly honored by the National Academy of Medicine in 1994 as recipients of the Rhoda and Bernard Sarnat International Prize in Mental Health. [8] In 1996, they jointly received the Joseph Zubin Award established by the American Psychopathological Association for seminal contributions to psychopathology research.
Weissman has received numerous other awards for her accomplishments, including but not limited to the Rema Lapouse Award for significant contributions to psychiatric epidemiology in 1985, the Joseph Zubin Award for lifetime achievement from the Society for Research in Psychopathology in 1995, [9] the Distinguished Service Award from the American Psychiatric Association in 2001, [10] the Gold Medal Award from the Society of Biological Psychiatry in 2007, and Thomas William Salmon Medal from the New York Academy of Medicine in 2009. [11] In the same year, she was selected by the American College of Epidemiology as 1 of 19 epidemiologists in the United States who has had an impact on public policy and health. The summary of her work on depression appeared in a special issue of the Annals of Epidemiology Triumphs in Epidemiology. In 2019, she was invited to give the named lecture (100 years of women) at Yale University. In 2020, she received the Pardes Humanitarian Award from the Brain and Behavioral Research Foundation. In 2021, she received the Research Prize from the American Psychiatric Association.
Weissman completed her bachelor's degree with honors at Brandeis University in 1956. She obtained a Masters in Social Work from the University of Pennsylvania in 1958, and subsequently worked as a psychiatric social worker in Chicago, IL, Glasgow, Scotland, and at the National Institutes of Health in Bethesda, MD. Weissman completed her PhD in Chronic Disease Epidemiology at the Yale University School of Medicine in 1974, and subsequently joined the faculty of the Departments of Psychiatry and Epidemiology at Yale University of School of Medicine, where she became a Tenured Professor and remained until 1987. [12] In 1987, Weissman became Chief of the Division of Clinical and Genetic Epidemiology, later renamed Translational Epidemiology, at the New York State Psychiatry Institute, and Professor of Epidemiology in Psychiatry at Columbia University. [13] In 2017, she received the Diane Goldman Kemper Family Professor at Columbia.
Weissman had four children by her marriage to Sherman Weissman, including Jonathan Weissman [14] and seven grandchildren including Rachel Weissman. She was married to her research collaborator Gerald Klerman for seven years until his death in 1992. [15] She later married Nobel Prize laureate Marshall Nirenberg. After Nirenberg's death in 2010, Weissman submitted his papers and the Nobel Prize to the National Library of Medicine. [16] In 2018, she married James Frauenthal, an applied Mathematician and a philanthropist.
Weissman is widely regarded as an expert on clinical depression. [17] Her early work, in collaboration with Gerald Klerman, focused on the efficacy of interpersonal therapy as treatment for major depression and other disorders. [18] She developed keen interest in maternal depression and its impact on the development of child psychopathology. In collaborative work, Weissman studied parent, the offspring, and later grandchildren of depressed parents to study the transmission of depression and other disorders across generations. She demonstrated the strong transmission and the enduring nature of depression across the lifespan [19] Weissman and her colleagues examined gender differences in rates of depression, posttraumatic stress disorder and other conditions, [20] [21] and examined genetic and psychosocial factors related to depression. [22] Weissman led a cross-national study of the epidemiology of major depression and bipolar disorder, which documented many similarities in the diagnosis of depression and bipolar disorder across countries, including the United States, Canada, France, West Germany, Italy, Lebanon, Taiwan, Korea, and New Zealand. [23] In her current research, she is interested in bringing psychiatric epidemiology closer to translational studies in the neuroscience in order to understand mechanisms of transmission and in using large datasets to understand mechanism of transmission and to replicate findings from smaller studies. She has published over 600 scientific articles and 11 books. Her H index as of September 2021 was 182 (165869 citations) i110 index 686.
Scholia has a profile for Myrna M. Weissman (Q37392598). |
Complete list of her published work in bibliography: http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/45244397/?sort=date&direction=ascending
Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of pervasive low mood. Low self-esteem, loss of interest in normally enjoyable activities, low energy, and pain without a clear cause are common symptoms. Those affected may also occasionally have delusions or hallucinations. Some people have periods of depression separated by years, while others nearly always have symptoms present. Major depression is more severe and lasts longer than sadness, which is a normal part of life.
A mental disorder, also called a mental illness or psychiatric disorder, is a behavioral or mental pattern that causes significant distress or impairment of personal functioning. Such features may be persistent, relapsing and remitting, or occur as a single episode. Many disorders have been described, with signs and symptoms that vary widely between specific disorders. Such disorders may be diagnosed by a mental health professional, usually a clinical psychologist or psychiatrist.
Mood disorder, also known as mood affective disorders, is a group of conditions of mental and behavioral disorder where a disturbance in the person's mood is the main underlying feature. The classification is in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International Classification of Diseases (ICD).
John C. Markowitz is an American physician, a Professor of Clinical Psychiatry at the Columbia University College of Physicians & Surgeons and a Psychiatric Researcher at the New York State Psychiatric Institute. For several decades he has conducted research on psychotherapies and medications as treatments for mood disorders, anxiety disorders, and personality disorders. He is currently conducting an outcome study of three psychotherapies for posttraumatic stress disorder (PTSD) thanks to a five-year grant from the National Institute of Mental Health. He is most widely published in the area of interpersonal psychotherapy or IPT, a manualized form of treatment, in which he was trained by the late Gerald L. Klerman, M.D. Dr. Markowitz is a graduate of Columbia University and Columbia University College of Physicians and Surgeons and received his psychiatric residency training at the Payne Whitney Psychiatric Clinic of Cornell University Medical School/New York-Presbyterian Hospital.
The Hamilton Rating Scale for Depression (HRSD), also called the Hamilton Depression Rating Scale (HDRS), sometimes also abbreviated as HAM-D, is a multiple-item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery. Max Hamilton originally published the scale in 1960 and revised it in 1966, 1967, 1969, and 1980. The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms.
Interpersonal psychotherapy (IPT) is a brief, attachment-focused psychotherapy that centers on resolving interpersonal problems and symptomatic recovery. It is an empirically supported treatment (EST) that follows a highly structured and time-limited approach and is intended to be completed within 12–16 weeks. IPT is based on the principle that relationships and life events impact mood and that the reverse is also true. It was developed by Gerald Klerman and Myrna Weissman for major depression in the 1970s and has since been adapted for other mental disorders. IPT is an empirically validated intervention for depressive disorders, and is more effective when used in combination with psychiatric medications. Along with cognitive behavioral therapy (CBT), IPT is recommended in treatment guidelines as a psychosocial treatment of choice for depression.
In medicine, a prodrome is an early sign or symptom that often indicates the onset of a disease before more diagnostically specific signs and symptoms develop. It is derived from the Greek word prodromos, meaning "running before". Prodromes may be non-specific symptoms or, in a few instances, may clearly indicate a particular disease, such as the prodromal migraine aura.
Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of mental disorders. These include various maladaptations related to mood, behaviour, cognition, and perceptions. See glossary of psychiatry.
Depression is a symptom of some physical diseases; a side effect of some drugs and medical treatments; and a symptom of some mood disorders such as major depressive disorder or dysthymia. Physical causes are ruled out with a clinical assessment of depression that measures vitamins, minerals, electrolytes, and hormones. Management of depression may involve a number of different therapies: medications, behavior therapy, psychotherapy, and medical devices.
A depression rating scale is a psychiatric measuring instrument having descriptive words and phrases that indicate the severity of depression for a time period. When used, an observer may make judgements and rate a person at a specified scale level with respect to identified characteristics. Rather than being used to diagnose depression, a depression rating scale may be used to assign a score to a person's behaviour where that score may be used to determine whether that person should be evaluated more thoroughly for a depressive disorder diagnosis. Several rating scales are used for this purpose.
Depression is a mental disorder characterized by prolonged unhappiness or irritability, accompanied by a constellation of somatic and cognitive signs and symptoms such as fatigue, apathy, sleep problems, loss of appetite, loss of engagement; low self-regard or worthlessness; difficulty concentrating or indecisiveness; or recurrent thoughts of death or suicide. Depression in childhood and adolescence is similar to adult major depressive disorder, although young sufferers may exhibit increased irritability or behavioral dyscontrol instead of the more common sad, empty, or hopeless feelings seen with adults. Children who are under stress, experiencing loss, have attention, learning, behavioral, or anxiety disorders are at a higher risk for depression. Childhood depression is often comorbid with mental disorders outside of other mood disorders; most commonly anxiety disorder and conduct disorder. Depression also tends to run in families. In a 2016 Cochrane review cognitive behavior therapy (CBT), third wave CBT and interpersonal therapy demonstrated small positive benefits in the prevention of depression. Psychologists have developed different treatments to assist children and adolescents suffering from depression, though the legitimacy of the diagnosis of childhood depression as a psychiatric disorder, as well as the efficacy of various methods of assessment and treatment, remains controversial.
Yuval Neria is a Professor of Medical Psychology at the Departments of Psychiatry and Epidemiology at Columbia University Medical Center (CUMC), and Director of Trauma and PTSD Program, and a Research Scientist at the New York State Psychiatric Institute (NYSPI) and Columbia University Department of Psychiatry. He is a recipient of the Medal of Valor, Israel's highest decoration, for his exploits during the 1973 Yom Kippur War.
Late-life depression refers to a major depressive episode occurring for the first time in an older person. The term can also include depression that develops in an older person who suffered from the illness earlier in life. Concurrent medical problems and lower functional expectations of elderly patients often obscure the degree of impairment. Typically, elderly patients with depression do not report depressed mood, but instead present with less specific symptoms such as insomnia, anorexia, and fatigue. Elderly persons sometimes dismiss less severe depression as an acceptable response to life stress or a normal part of aging.
Gerald L. Klerman was an American psychiatrist and researcher whose work included the development of interpersonal psychotherapy, a short-term treatment for depression. He was chief of the US national mental health agency from 1977 to 1980.
The following outline is provided as an overview of and topical guide to psychiatry:
The epidemiology of depression has been studied across the world. Depression is a major cause of morbidity worldwide, as the epidemiology has shown. Lifetime prevalence estimates vary widely, from 3% in Japan to 17% in the United States. Epidemiological data shows higher rates of depression in the Middle East, North Africa, South Asia and U.S.A than in other countries. Among the 10 countries studied, the number of people who would suffer from depression during their lives falls within an 8–12% range in most of them.
Prolonged grief disorder (PGD) refers to a syndrome consisting of a distinct set of symptoms following the death of a loved one. PGD is experienced by about 10 percent of bereaved survivors, though rates vary depending on the circumstances. The affected person is incapacitated by grief, so focused on the loss that it is difficult to care about much else. He or she often ruminates about the death and longs for a reunion with the departed, while feeling unsure of his or her own identity and place in the world. The victim will develop a flat and dull outlook on life, feeling that the future holds no prospect of joy, satisfaction or pleasure. The bereaved person who suffers from PGD feels devalued and in constant turmoil, with an inability to adjust to life without the beloved.
Eugene Stern Paykel is a British psychiatrist. He is known for his research work on depression, clinical psychopharmacology and social psychiatry over more than 40 years.
Ellen Frank is a psychologist and Distinguished Professor Emeritus of Psychiatry and Distinguished Professor of Psychology at the University of Pittsburgh. She is known in the field of Psychotherapy as one of the developers of Interpersonal and Social Rhythm Therapy, which aims to treat bipolar disorder by correcting disruptions in the circadian rhythm while promoting increased regularity of daily social routines. Frank is the co-founder and Chief Scientific Officer of HealthRhythms, a company that uses mobile technology to monitor the health and mental health of clients, facilitate the detection of changes in their status, and better manage mental health conditions.
Judy Garber is a clinical psychologist known for her research on emotional dysregulation and mood disorders, with a focus on cognitive-behavioral interventions for adolescents who suffer from depression. Garber is Cornelius Vanderbilt Professor of Psychology and Human Development at Vanderbilt University.